20.3 Older Adult Medicine, Frailty, Falls, Polypharmacy, and Osteoporosis

Key Takeaways

  • Comprehensive geriatric assessment combines medical, functional, cognitive, psychological, social and environmental findings in a shared care plan. Grade frailty using usual function before the acute illness.

  • Acute change in attention or alertness prompts a 4AT and clinical assessment. Treat precipitating factors and support orientation. Haloperidol is contraindicated in Parkinson's disease and dementia with Lewy bodies.

  • A sustained orthostatic drop of at least 20 mmHg systolic or 10 mmHg diastolic within three minutes supports classical orthostatic hypotension. Use STOPP/START and clinical goals to review fall-risk medicines and hypoglycaemia.

  • Start urgency incontinence treatment with bladder training. Consider mirabegron when antimuscarinics are unsuitable and check blood pressure, kidney function and interactions.

  • After a fragility fracture, address falls and secondary fracture prevention. Use product-specific oral bisphosphonate instructions, check renal limits, and plan calcium monitoring and continuity before starting denosumab.

Last updated: November 2026

Comprehensive Geriatric Assessment, Frailty, and Delirium

Managing multimorbidity in later life includes agreeing goals that matter to the person, such as maintaining mobility, cognition or the ability to live at home.

Comprehensive Geriatric Assessment (CGA) and Frailty

Comprehensive Geriatric Assessment (CGA) is a multidimensional, interdisciplinary process that turns assessment into a shared care plan with named actions, follow-up and reassessment. Trials of inpatient CGA show a greater likelihood of being alive and at home after discharge. A structured CGA spans five domains:

  1. Medical Domain: Active comorbidities, nutrition, continence, sensory deficits (vision/hearing), and structured medication reconciliation.
  2. Functional Domain: Basic Activities of Daily Living (ADLs)—bathing, dressing, toileting, transferring, continence, feeding—and Instrumental Activities of Daily Living (IADLs)—shopping, meal preparation, managing finances, telephone use, transport, and taking medications reliably.
  3. Cognitive and Psychological Domain: Baseline cognitive trajectory (collateral history from family/carers), delirium screening (4AT), and screening for late-life depression.
  4. Social Domain: Informal carer strain, formal home-support packages, isolation, and financial or legal arrangements.
  5. Environmental Domain: Home fall hazards (loose rugs, poor lighting, stairs without handrails, bathroom adaptations).

Frailty is increased vulnerability to stressors because physiological reserve is reduced. The Clinical Frailty Scale (CFS) uses clinical judgement about an older person's usual function before the current illness. In acute care the developers use the baseline two weeks earlier. Check the baseline with the person or an informant. CFS 1–3 ranges from very fit to managing well. CFS 4 describes very mild frailty, with symptoms limiting activities despite no need for daily help. CFS 5 usually involves help with more complex activities such as finances, transport or heavy housework. At CFS 6, help extends to outside activities and often bathing, with some help with dressing possible. At CFS 7, the person depends on others for personal care but can be clinically stable. CFS 8 describes very severe frailty with complete dependence and limited ability to recover from minor illness. CFS 9 describes a terminal illness with life expectancy under six months in someone who is not otherwise severely frail.

Atypical presentations. Because physiological reserve is blunted, acute life-threatening illness in frail older adults frequently manifests atypically without classic localising features:

  • Myocardial infarction presenting as sudden dyspnoea, syncope, or delirium without chest pain;
  • Sepsis or pneumonia presenting without fever (normothermia or hypothermia) as "off legs" (sudden immobility), acute confusion, or recurrent falls;
  • Abdominal emergencies may present with vague symptoms. New anorexia or functional decline with abdominal findings warrants assessment.

Delirium vs Dementia: Screening, Reversible Triggers, and Safe Management

FeatureDelirium (Acute Confusional State)Dementia (Major Neurocognitive Disorder)
Onset & CourseAcute (hours to days); fluctuates over hours or across the dayUsually insidious over months or years. Compare changes with the person’s usual pattern.
Attention (Hallmark)Impaired ability to sustain or shift attention, which may vary during the assessment.May be relatively preserved early in Alzheimer disease. Dementia with Lewy bodies can itself cause fluctuation.
Consciousness / ArousalAltered: hyperactive (agitated), hypoactive (quiet and drowsy, which can be missed), or mixedOften preserved early. Use the individual baseline and clinical course.
Screening Tool4AT (Alertness, AMT4, Attention, Acute change/fluctuation; score ≥4\ge 4 = possible delirium)Assess baseline from history and records. Reassess persistent cognitive impairment after the acute illness.

Important

Collateral History Rule: Seek baseline information from the person, family or carers, and prior records. Start assessment and treatment of likely delirium while obtaining collateral history. Hypoactive delirium can coexist with dementia and is easily mistaken for fatigue or depression.

Identifying Reversible Causes (PINCH ME):

  • Pain (unrecognised hip fracture, ischaemia, pressure sore)
  • Infection (examine for a source such as pneumonia or cellulitis. In adults 65 and over, use the clinical UTI pathway instead of urine dipstick results to diagnose infection.)
  • Nutrition and metabolic disturbance (hypoglycaemia, hyponatraemia, hypercalcaemia, uraemia)
  • Constipation or urinary retention
  • Hydration / hypoxia
  • Medications (anticholinergics, opioids, benzodiazepines, steroids, alcohol withdrawal)
  • Environment (ward transfers, sleep deprivation, missing spectacles/hearing aids)

Management. Treat identified precipitants and support orientation, sleep, hydration, sensory aids and safe mobilisation. For severe distress or risk of harm after de-escalation, consider short-term medication only after clinical review. If haloperidol is suitable, check contraindications and cardiac risk, start at the lowest appropriate dose and reassess. Parkinson's disease, dementia with Lewy bodies and known QT prolongation are contraindications. Seek urgent senior or specialist advice if medication is necessary in Parkinson's disease or dementia with Lewy bodies. Suspected withdrawal and end-of-life agitation have separate treatment pathways. HSE CGA guidance · Clinical Frailty Scale · 4AT scoring · EMA haloperidol product information

Falls, Orthostatic Syncope, Polypharmacy, and Urinary Incontinence

Multifactorial Falls and Syncope Assessment

For a community presentation, clarify whether the event was a trip, a fall with injury, or possible transient loss of consciousness. Frailty, two or more falls in a year, an injury requiring treatment, inability to get up independently or possible loss of consciousness trigger comprehensive assessment. For a single fall without those features, assess gait and balance and direct further care to the findings.

  1. Event and collateral history. Ask about position, trigger, prodrome, loss of consciousness, injuries and recovery. Lightheadedness after standing suggests an orthostatic mechanism. Collapse during exertion, a new murmur, palpitations or an abnormal ECG raises concern for a cardiac cause. A witness account can help distinguish a faint from a seizure.
  2. Lying and standing blood pressure. After at least five minutes supine, measure BP and pulse. If safe, repeat on standing within the first minute and serially through three minutes. A sustained decrease of at least 20 mmHg systolic or 10 mmHg diastolic within three minutes supports classical orthostatic hypotension. Some autonomic criteria use a 30 mmHg systolic fall in supine hypertension. Record symptoms and review volume status, autonomic disease and medicines such as alpha-blockers, diuretics, nitrates, dopaminergic drugs and tricyclics. Exertional collapse or an abnormal ECG still requires assessment even when a BP drop is present.
  3. Examination and prevention. Include cardiovascular and neurological examination, a 12-lead ECG when syncope is suspected, visual acuity, gait, strength, footwear and use of mobility aids. Observe transfers, walking and turning, for example with Timed Up and Go. Use the findings to plan progressive strength and balance work, home-hazard reduction, vision correction or a medication review. A gait-test cutoff alone cannot establish an individual's risk.

Polypharmacy and Deprescribing Using STOPP/START

STOPP/START originated in Ireland. STOPP identifies potentially inappropriate medicines and START identifies potentially beneficial omitted treatments. Use the current criteria with medication reconciliation, indication, expected benefit, kidney function, interactions, adverse effects, withdrawal risk and the person's goals.

Review promptExampleClinical reasoning
Sedation and balanceReview long-term benzodiazepines and Z-drugs after falls.Chronic benzodiazepines generally need gradual reduction. Check the indication and plan follow-up.
Anticholinergic effectsReview amitriptyline when cognition, constipation, urinary emptying or orthostasis are affected.Adding an antimuscarinic can compound the same harms.
Bleeding and renal riskReconsider an oral NSAID in someone with CKD or high GI bleeding risk.Review analgesic benefit alongside kidney function, fluid status and co-prescribed drugs.
Treatment durationReview continued full-dose PPI after treatment of uncomplicated reflux.Establish the indication before stepping down. A continuing gastroprotection indication may require maintenance.
HypoglycaemiaReview sulfonylureas, particularly long-acting agents and any regimen with documented hypoglycaemia.Set an individual glucose goal based on frailty, function, comorbidities and symptoms. An HbA1c value alone cannot identify the cause of a fall.
Omitted preventionReview bone protection after a fragility fracture and a bowel regimen with regular opioids.Match the regimen to fracture and renal risk or to the opioid and the person's bowel symptoms.

Urinary Incontinence in Older Adults

Identify onset, bladder symptoms, mobility and functional impact. Look for reversible contributors using DIAPPERS: delirium, infection, atrophic genitourinary changes, pharmaceuticals, psychological factors, excess urine output, restricted mobility and stool impaction. A bladder diary can show a pattern. In adults 65 and over, investigate suspected UTI on clinical grounds under the Irish pathway and obtain a urine sample for culture when indicated. Dipstick results are unreliable for this purpose.

  • Stress incontinence. Leakage with coughing, laughing or exertion. For women, offer supervised pelvic floor muscle training for at least three months. Consider vaginal oestrogen when there are associated genitourinary symptoms and signs of menopause.
  • Urgency incontinence. Urgency, frequency and nocturia may accompany leakage. Start with bladder training for at least six weeks and reduce excess caffeine. If symptoms persist and antimuscarinics are unsuitable, consider mirabegron, a beta-3 agonist. Check BP before and during treatment. Severe uncontrolled hypertension, systolic at least 180 mmHg or diastolic at least 110 mmHg, is a contraindication. Check renal and hepatic function and interactions for the selected product. Avoid immediate-release oxybutynin in older women at higher risk of sudden physical or mental deterioration. Consider the total anticholinergic burden when selecting any antimuscarinic.
  • Overflow incontinence. Dribbling plus poor stream, straining or incomplete emptying suggests retention. Check post-void residual if voiding dysfunction is suspected and interpret it alongside symptoms, renal function and the clinical setting. Address constipation, medicine effects or obstruction and seek urgent assessment if acute retention is present.
  • Functional incontinence. The person cannot reach or use the toilet in time because of mobility, dexterity, cognition or environment. Prompted voiding, accessible toilets and mobility or clothing adaptations may help.

World Falls Guidelines · STOPP/START v3 · HSE guidance for UTI in adults aged 65 and over · HPRA mirabegron Clonmel product information

Loading diagram...
Multifactorial Geriatric Falls and Delirium Review Framework

Osteoporosis, Fragility Fractures, and Capacity in Ireland

Diagnosis and Fracture Risk

A fragility fracture follows low-energy trauma, typically a fall from standing height or less. Common sites include hip, vertebrae, distal radius and proximal humerus.

  • T-scores compare bone mineral density with a young-adult reference. In postmenopausal women and men aged 50 or older, a valid lumbar spine, total hip or femoral neck T-score of −2.5 or lower meets the densitometric definition of osteoporosis. A score below −1.0 but above −2.5 is low bone mass. A score of −1.0 or higher is in the normal range. At the hip, use the lower of the valid femoral neck and total hip values.
  • Z-scores use an age-matched reference and are preferred before menopause and in men younger than 50. A Z-score of −2.0 or lower is below the expected range for age. Assess the clinical context and secondary causes. Bone density alone cannot diagnose osteoporosis in men under 50.
  • FRAX estimates ten-year hip fracture and major osteoporotic fracture probabilities using clinical risk factors, with or without femoral neck BMD. Use the Ireland model when applicable. A major osteoporotic fracture in FRAX means a clinical vertebral, hip, forearm or proximal humeral fracture. Falls history, a recent fracture and glucocorticoid dose need clinical interpretation alongside the output.

Worked example. A 73-year-old with a low-trauma vertebral fracture has a lumbar T-score of −1.8 and femoral neck T-score of −2.2. Both are in the low bone mass range. The vertebral fracture already identifies high future fracture risk and warrants secondary prevention. If FRAX is used in the assessment, enter femoral neck BMD. Neither the spinal score nor the arithmetic mean of the two scores is a FRAX input.

Hip fracture pathway. After a fall with new hip pain or inability to bear weight, assess for hip fracture, obtain radiographs and arrange further imaging if suspicion persists after negative X-rays. Provide prompt analgesia, assess reversible perioperative problems and involve orthopaedics and orthogeriatrics. The Irish Hip Fracture Database standard in use in 2026 audits surgery within 48 hours of first presentation and within normal working hours. The revised orthogeriatric and delirium standards apply to discharges from 1 January 2027. Aim for prompt surgery and physiotherapy-led mobilisation on the day of surgery or the next day when feasible. Address delirium and pressure injury risk. Arrange falls assessment, bone protection and follow-up before discharge, without waiting for routine DXA if an older patient already has a hip or vertebral fragility fracture.

Secondary Causes and Glucocorticoids

Check clinical risk factors and use a baseline work-up such as full blood count, renal function, calcium, phosphate, alkaline phosphatase and vitamin D. Additional tests depend on the presentation. Investigate possible myeloma when vertebral fractures coexist with unexplained anaemia or other suggestive findings. Consider thyroid, parathyroid or coeliac testing and, when indicated, testosterone in men. Review systemic glucocorticoids, aromatase inhibitors, androgen deprivation and enzyme-inducing antiseizure medicines.

Assess fracture risk when starting prolonged systemic glucocorticoids. A prior fragility fracture or other high-risk features may justify bone protection at initiation. For example, the UK NOGG guideline advises starting bone protection without waiting for DXA in postmenopausal women and men aged at least 50 who start at least 7.5 mg/day prednisolone equivalent for the next three months, and in other specified high-risk groups. Use local guidance and evaluate eligibility, renal function, calcium and vitamin D.

Osteoporosis Pharmacotherapy and Safety Counselling

AgentWhen to consider itAdministration and safety
AlendronateWeekly oral treatment when appropriate.For Fosamax 70 mg, swallow whole on rising with at least 200 mL plain water. Wait at least 30 minutes before food, drink or other medication. Remain upright for at least 30 minutes and until after the first food. Contraindications include hypocalcaemia, delayed oesophageal emptying and inability to stay upright for 30 minutes. Use is not recommended when creatinine clearance is below 35 mL/min. Check the actual product for instructions and renal limits.
Zoledronic acidIV option if oral treatment is unsuitable or after hip fracture.For osteoporosis, Aclasta 5 mg IV once yearly over at least 15 minutes. Calculate creatinine clearance before dosing using Cockcroft–Gault with actual body weight. It is contraindicated below 35 mL/min and in hypocalcaemia. Ensure appropriate hydration and address calcium and vitamin D status. A transient influenza-like reaction may follow the first infusion.
DenosumabProlia 60 mg SC every six months for eligible patients. Plan continuity before starting.Correct hypocalcaemia and ensure adequate calcium and vitamin D. Check calcium before each dose, and within two weeks after the first dose in predisposed patients. Severe renal impairment and dialysis confer higher risk of severe or fatal hypocalcaemia even though no renal dose adjustment is required. Arrange regular monitoring and specialist care in that setting.
Teriparatide or romosozumabSpecialist options in selected patients at very high fracture risk.Forsteo treatment is limited to 24 months and Evenity to 12 monthly doses. Plan follow-on antiresorptive therapy. In the EU, prior myocardial infarction or stroke contraindicates romosozumab.

An unplanned delay or discontinuation of denosumab increases the risk of vertebral fractures, including multiple fractures. Arrange specialist-led follow-on treatment before stopping. One option for eligible patients is IV zoledronic acid six months after the last denosumab dose. Severe renal impairment can preclude that option and calls for a specialist plan.

Rare risks of antiresorptives include osteonecrosis of the jaw and atypical femoral fracture. Encourage oral hygiene and arrange preventive dental assessment when risk factors warrant it. Assess new thigh, hip or groin pain for an incomplete femoral fracture and consider the contralateral femur if an atypical fracture is found. Reassess fracture risk after about five years of oral bisphosphonate or three years of IV zoledronic acid. A treatment pause depends on residual fracture risk and the drug used. Denosumab requires a planned transition.

Supported Decision-Making and Ward Prevention

  • Capacity and consent. Ireland's Assisted Decision-Making (Capacity) Act 2015, as amended, presumes capacity. Take practicable steps to support the specific decision at the time it is needed. Check whether the person can understand, retain, use or weigh the relevant information and communicate a choice by any means. A dementia diagnosis, age or an unwise decision does not establish incapacity. Use communication supports and seek the person's will and preferences. Verify the scope of any formal supporter or court order. A refusal in a valid, applicable advance healthcare directive is binding when the person lacks capacity for that treatment, subject to statutory exceptions. For life-sustaining treatment, the directive must expressly apply even if life is at risk.
  • Time-critical Parkinson's therapy. Reconcile actual dose times and formulations on admission. Delays and abrupt withdrawal can cause severe immobility, swallowing problems and, rarely, parkinsonism-hyperpyrexia syndrome. If oral administration is unsafe, urgently involve pharmacy and the Parkinson's team for a suitable alternative route and conversion. Avoid dopamine blockers such as metoclopramide, prochlorperazine and haloperidol. Check alternatives against cardiac risk and interactions. Ondansetron is contraindicated with apomorphine.
  • Nutrition and sarcopenia. Use a validated malnutrition screening tool such as MUST. Follow a positive screen with assessment and an individualised intake and support plan. Low grip strength or poor chair-rise performance suggests sarcopenia, with muscle quantity or quality used for confirmation where appropriate. Tailor progressive resistance exercise and protein to function, intake and comorbidities. A general older-adult reference is at least 1 g protein/kg/day, adjusted individually. For high refeeding risk, involve the clinical nutrition team, give thiamine, monitor phosphate, magnesium and potassium, and use a monitored feeding plan.
  • Pressure injury. Assess risk using clinical judgement and the local risk tool. Follow the HSE aSSKINg prevention bundle with skin inspection, a suitable pressure-redistributing surface, individualised repositioning, heel offloading, moisture care, nutrition and hydration. Inspect bony prominences and skin under devices. Avoid rubbing or massaging pressure areas.

Irish Hip Fracture Database 2025 report · ISCD adult positions · FRAX calculator · EMA Aclasta product information · EMA Prolia product information · Irish Medication Safety Network Parkinson alerts

Test Your Knowledge

An 83-year-old woman with mild Alzheimer's dementia becomes unusually quiet and sleepy on the second day after fixation of a wrist fracture. She is clearly drowsy throughout assessment, answers all four AMT4 questions correctly and can recite only December, November and October backwards. Her family confirms that she was alert and conversing normally three days ago. Which interpretation and initial management priority is correct?

A

Suspect hypoactive delirium and promptly assess reversible precipitants while supporting orientation.

B

Attribute the change to dementia progression and reassess at her next routine appointment.

C

Treat hyperactive delirium with immediate intramuscular haloperidol before examining her.

D

Treat late-life depression with immediate amitriptyline.

Test Your Knowledge

An 80-year-old man with type 2 diabetes, hypertension, benign prostatic hyperplasia and moderate frailty reports two dizzy episodes after getting out of bed. After five minutes supine his BP is 148/82 mmHg. It is 114/68 mmHg at two minutes standing with lightheadedness and remains 114/68 at three minutes. He takes gliclazide MR, doxazosin, ramipril, bendroflumethiazide and amitriptyline. His latest HbA1c is 46 mmol/mol. On a separate morning his capillary glucose was 3.2 mmol/L during sweating before breakfast. Which medication plan best addresses his risks?

A

Intensify antihypertensive therapy to lower his supine BP below 120/70 mmHg.

B

Replace amitriptyline with immediate-release oxybutynin and retain the other medicines.

C

Review and reduce medicines contributing to orthostasis and falls, and deintensify gliclazide with an individual glucose goal.

D

Continue current therapy and advise him to rise from bed more quickly.

Test Your Knowledge

A 79-year-old woman with moderate vascular dementia, recurrent falls and BP 134/78 mmHg has had urgency, frequency and urgency leakage for six months. There is no new dysuria, fever or other clinical evidence of infection. Post-void residual is 35 mL and eight weeks of supervised bladder training gave partial relief. Her eGFR is 62 mL/min/1.73 m², with no hepatic impairment or relevant interacting medicines. Antimuscarinic therapy is unsuitable because of cognitive vulnerability. Which medicine best addresses the persistent bladder symptoms?

A

Immediate-release oxybutynin 5 mg three times daily

B

Start Mirabegron Clonmel 25 mg prolonged-release once daily with food, with BP monitoring

C

Furosemide 40 mg in the evening

D

Doxazosin 4 mg once daily

Test Your Knowledge

A 72-year-old woman undergoes hemiarthroplasty for a low-trauma femoral neck fracture and starts Fosamax 70 mg once weekly. Four years later she has stage 4 CKD with a stable eGFR of 26 mL/min/1.73 m². A specialist plans a change to Prolia after reviewing her bone and mineral status, correcting hypocalcaemia and checking vitamin D. Which counselling covers both treatment phases?

A

Take Fosamax at bedtime with milk, and stop Prolia without follow-up when injections are inconvenient.

B

Chew Fosamax before breakfast, and restrict water for two hours after each Prolia injection.

C

Avoid Fosamax whenever kidney function is normal, and use Prolia without calcium monitoring.

D

Take Fosamax with plain water on rising and stay upright as directed. Arrange calcium monitoring and a specialist plan before any Prolia delay or discontinuation.

Sections you finish are checked off in the contents.